Catecholic flavonoids acting as telomerase inhibitors

Journal of Medicinal Chemistry

Volumn 47, Issue 26, 2004, Pages 6466-6475

  Menichincheri, Maria ^a   Ballinari, Dario ^a   Bargiotti, Alberto ^a   Bonomini, Luisella ^a   Ceccarelli, Walter ^a   D'Alessio, Roberto ^a   Fretta, Antonella ^a   Moll, Juergen ^a   Polucci, Paolo ^a   Soncini, Chiara ^a   Tibolla, Marcellino ^a   Trosset, Jean Yves ^a   Vanotti, Ermes ^a  

^a NERVIANO MEDICAL SCIENCES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

7,8,3,4 TETRAHYDROXYFLAVONE; CATECHOL; FLAVONE DERIVATIVE; FLAVONOID; TELOMERASE; TELOMERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG SCREENING; DRUG STRUCTURE; HYDROXYLATION; IN VITRO STUDY; ONCOLOGY; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

ANTINEOPLASTIC AGENTS; CATECHOLS; FLAVONES; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP; TELOMERASE;

EID: 10644284737     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm040810b     Document Type: Article

References (41)

1. Collins, K. Mammalian telomeres and telomerase. Curr. Opin. Cell. Biol. 2000, 12, 378-383.
2. Harley, C. B. Telomere loss: mitotic clock or genetic time bomb? Mutat. Res. 1991, 256, 271-282.
3. Shay, W. J.; Wright, W. E.; Werbin, H. Defining the molecular mechanisms of human cell immortalization. Biochim. Biophys. Acta - Rev. Cancer 1991, 1072, 1-7.
4. Shay, W. J.; Bacchetti S. A Survey of Telomerase Activity in Human Cancer. Eur. J. Cancer 1997, 33, 787-791.
5. Perry; P. J.; Jenkins, T. C. Recent advances in the development of telomerase inhibitors for the treatment of cancer. Exp. Opin. Invest. Drugs 1999, 8 (12), 1981-2008.
6. Neidle, S.; Kelland, L. R. Telomerase as an anti-cancer target: current status and future prospects. Anti-Cancer Drug Des. 1999, 14, 341-347.
7. Ueno, T.; Takahashi, H.; Oda, M.; Mizunuma, M.; Yokoyama, A.; Goto, Y.; Mizushina, Y.; Sagakuchi, K.; Hayashi, H. Inhibition of Human Telomerase by Rubromycins: Implication of Spiroketal System of the Compounds as an Active Moiety. Biochemistry 2000, 39, 5995-6002.
8. Ken-ichi, T.; Hideaki, K.; Masayuki, M.; You-Xin, S.; Hiroyuki, O. Inhibition of human telomerase activity by alterperylenol. Oncol. Res. 1998, 10, 449-453.
9. Yuji, T.; Shuji, I.; Takashi, Y.; Toru, S.; Shigeru, H.; Sadatoshi, S.; Kazauo, S.; Haruo, S. Diazaphilonic acid a new azaphilone with telomerase inhibitory activity. J. Antibiot. 1999, 52, 412-414.
10. Naasani, I.; Seimiya, H.; Tsuruo, T. Telomerase Inhibition, Telomere Shortening, and Senescence of Cancer Cells by Tea Catechins. Biochem. Biophys. Res. Commun. 1998, 249, 391-396.
11. Sang Sun, K.; Seung Eu, L.; Growth and telomerase inhibition of SK-MEL 28 melanoma cell line by a plant flavonoid, apigenin. J. Biochem. Mol. Biol. 1998, 31, 339-344.
12. Deschner, E.; Ruperto, J.; Wong, G.; Newmark, H. L. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis 1991, 12 (7), 1193-1196.
13. Elangovan, V.; Sekar, N.; Govindasamy, S. Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis. Cancer Lett. 1994, 87, 107-113.
14. Kuo, S. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett. 1996, 110, 41-48.
15. Chu, S. C.; Hsieh, Y. S.; Lin, J. Y. Inhibitory effects of flavonoids on moloney murine leukemia virus reverse transcriptase activity. J. Nat. Prod. 1992, 55 (2), 179-183.
16. Ono, K.; Nakane, H.; Fukushima, M.; Chermann, J. C.; Barrè- Sinoussi, F. Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur. J. Biochem. 1990, 190, 469-476.
17. Badhwar, I. C.; Kang, K. S.; Venkataraman, K. Synthetical experiments in the chromone group. Part VII. Synthesis of 7,8,4′-trihydroxy-, 7,8,3′,4′-tetrahydroxy-, and 7,8,3′,4′,5′-, 5,7,3′,4′,5′-, and 3,7,3′,4′,5′- pentahydroxyflavones. J. Chem. Soc. 1932, 1107-1112.
18. Nagarathnam, D.; Cushman, M. A short and facile synthetic route to hydroxylated flavones. New syntheses of apigenin, tricin, and luteolin. J. Org. Chem. 1991, 56 (16), 4884-4887.
19. Klinke, P.; Gibian, H. Uber chalkone. Chem. Ber. 1961, 94, 26-38.
20. Baker, W. Molecular rearrangement of some o-acyloxyacetophenones and the mechanism of the production of 3-acylchromones. J. Chem. Soc. 1933, 1381-1388.
21. Mahal, H. S.; Venkataraman, K. Synthetical experiments in the chromone group. Part XIV. The action of sodamide on 1-acyloxy-2-acetonaphthones. J. Chem. Soc. 1934, 1767-1769.
22. Wheeler, T. S. Flavone. Organic Syntheses; Wiley: New York, 1963; Collect. Vol. IV, pp 478-481.
23. Kato, S.; Morie, T.; Yoshida, N. Synthesis and biological activity of 4-amino-5-chloro-2-ethoxy-3-hydroxybenzamides, metabolites of a new gastroprokinetic agent, mosapride. Chem. Pharm. Bull. 1996, 44 (8), 1484-1492.
24. Awad, W. I.; El-Neweihy, M. F.; Selim, S. F. Studies on 3-acylcathecols. II.1 A new synthesis of 8-hydroxyflavone. J. Org. Chem. 1960, 25 (8), 1333-1336.
25. Davis, F. A.; Han, W.; Murphy, C. K. Selective, electrophilic fluorinations using N-fluoro-o-benzenedisulfonimide. J. Org. Chem. 1995, 60 (15), 4730-4737
26. Pelter, A.; Ward, R. S.; Whalley, J. L. A facile synthesis of 2-substituted isoflavones for immunoassay: assembly of the isoflavonoid skeleton by means of a novel cyclisation reaction. Synthesis 1998, 12, 1793-1802.
27. De Meyer, N.; Haemers, A.; Mishra, L.; Pandey, H. K.; Pieters, L. A. C.; Vanden Berghe, D. A.; Vlietinck, A. J. 4-Hydroxy-3-methoxyflavones with potent antipicornavirus activity. J. Med. Chem. 1991, 34 (2), 736-746.
28. Newman, M. S.; Ferrari, J. L.; Garg, C. P. A new synthesis of 3-chloroflavones. J. Heterocycl. Chem. 1964, 1, 76-78.
29. Goker, H.; Ayhan, G.; Tuncbilek, M.; Ertan, R.; Leoncini, G.; Garzoglio, R.; Mazzei, M. Synthesis and antiaggregator activity of some new derivatives of 4H-1-benzopyran-4-one. Eur. J. Med. Chem. 1995, 30, 561-567.
30. Bhatt, M. V.; Kulkarni, S. U. Cleavage of ethers. Synthesis 1983, 4, 249-282.
31. Phillips, M. A. The formation of 2-methylbenzimidazoles. J. Chem. Soc. 1928, 172-177.
32. Goker, H.; Tuncbilek, M.; Ayhan, G.; Altanlar, N. Synthesis of some new benzimidazolecarboxamides and evaluation of their antimicrobial activity. Farmaco 1998, 53 (6), 415-420.
33. Nefzi, A.; Giulianotti, M. A.; Houghten, R. A. Solid-phase synthesis of branched thiohydantoin tetrahydroquinoxalinediones. Tetrahedron Lett. 2000, 41 (14), 2283-2287.
34. Asai, A.; Oshima, Y.; Yamamoto, Y.; Uochi, T.; Kusaka, H.; Akinaga, S.; Yamashita, Y.; Pongracz, K.; Pruzan, R.; Wunder, E.; Piatyszek, M.; Li, S.; Chin, A. C.; Harley, C. B.; Gryaznov, S. A Novel Telomerase Template Antagonist (GRN163) as a Potential Anticancer Agent. Cancer Res. 2003, 63 (14), 3931-3939.
35. Kim, N. W.; Piatyszek, M. A.; Prowse, K. R.; Harley, C. B.; West, M. D.; Ho, P. L. C.; Coviello, G. M.; Wright, W. E.; Weinrich, S. L.; Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266, 2011-2015.
36. Mukai, S.; Kondo, Y.; Koga, S.; Komata, T.; Barna, B. P.; Kondo, S. 2-5A Antisense telomerase RNA therapy for intracranial malignant gliomas. Cancer Res. 2000, 60 (16), 4461-4467.
37. Kotic, S.; Soskic, V.; Joksimovic, J. Synthesis and evaluation of several cathechol bioisosteres as potential dopamine receptor ligands. Bioorg. Med. Chem. Lett. 1991, 1 (8), 403-406.
38. Arnett, C. D.; Wright, J.; Zenker, N. Synthesis and adrenergic activity of benzimidazole bioisosteres of norepinephrine and isoproterenol. J. Med. Chem. 1978, 21, 72-78.
39. Perry, P. J.; Jenkins, T. C. DNA Tetraplex-binding drugs structure-selective targeting is critical for antitumor telomerase inhibition. Mini Rev. Med. Chem. 2001, 1 (1), 31-41.
40. Perry, P. J.; Gowan, S. M.; Reszka, A. P.; Polucci, P.; Jenkins, T. C.; Kelland, R. L.; Neidle, S. 1,4- and 2,6-Disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase. J. Med. Chem. 1998, 41, 3253-3260.
41. Caprio, V.; Guyen, B.; Opoku-Boahen, Y.; Mann, J.; Gowan, S. M.; Kelland, L. M.; Read, M. A.; Neidle, S. A novel inhibitor of human telomerase derived from 10H-indolo[3,2-b]quinoline. Bioorg. Med. Chem. Lett. 2000, 10 (18), 2063-2066.